Synthesis, Characterization and Biomedical Applications of p(HEMA-co-APTMACI) Hydrogels Crosslinked with Modified Silica Nanoparticles
| dc.contributor.author | Yilmaz, Betul | |
| dc.contributor.author | Özay, Özgür | |
| dc.date.accessioned | 2025-01-27T20:26:57Z | |
| dc.date.available | 2025-01-27T20:26:57Z | |
| dc.date.issued | 2022 | |
| dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
| dc.description.abstract | In this study, a new silica-based crosslinker was successfully synthesized with the reaction between silica nanoparticles modified with amino groups and glycidyl methacrylate (GMA). Using the synthesized silica-based crosslinker, p(HEMA) and p(HEMA-co-APTMACI) hydrogels were synthesized for use as drug carrier systems with the free radical polymerization method. The synthesized silica-based crosslinker and hydrogels were characterized using scanning electron microscopy (SEM) and Fourier transform-infrared spectroscopy (FTIR) devices. The swelling behavior of hydrogels cross-linked with silica was investigated in different physiological media. The hydrogels were loaded with sodium diclofenac (NaDc) as a model drug. Drug release studies from the obtained drug-loaded hydrogels were performed at 37 degrees C in PBS (pH 7.0) media. Additionally, the antibacterial properties of the hydrogels synthesized in the study were investigated against E. coli (gram-negative), B. subtilis, and S. aureus (gram-positive) bacteria using the disk diffusion method. At the end of the study, p(HEMA-co-APTMACI) hydrogels were determined to display a better drug release profile than p(HEMA) hydrogels. | |
| dc.description.sponsorship | Canakkale Onsekiz Mart University [FYL-2019-3106] | |
| dc.description.sponsorship | This research was funded by the Canakkale Onsekiz Mart University [FYL-2019-3106] . | |
| dc.identifier.doi | 10.33263/BRIAC123.36643680 | |
| dc.identifier.endpage | 3680 | |
| dc.identifier.issn | 2069-5837 | |
| dc.identifier.issue | 3 | |
| dc.identifier.scopus | 2-s2.0-85112370737 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 3664 | |
| dc.identifier.uri | https://doi.org/10.33263/BRIAC123.36643680 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12428/22514 | |
| dc.identifier.volume | 12 | |
| dc.identifier.wos | WOS:000686904100064 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Biointerface Research Applied Chemistry | |
| dc.relation.ispartof | Biointerface Research in Applied Chemistry | |
| dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20250125 | |
| dc.subject | (3-acrylamidopropyl) trimethylammonium chloride | |
| dc.subject | 2-hydroxyethyl methacrylate | |
| dc.subject | silica-based crosslinker | |
| dc.subject | drug release | |
| dc.subject | hydrogel | |
| dc.title | Synthesis, Characterization and Biomedical Applications of p(HEMA-co-APTMACI) Hydrogels Crosslinked with Modified Silica Nanoparticles | |
| dc.type | Article |











